Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 7, 1998, Pages 2255-2259

  Carling, Tobias ^a   Rastad, Jonas ^a   Åkerström, Göran ^a   Westin, Gunnar ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; MESSENGER RNA; PARATHYROID HORMONE; VITAMIN D; VITAMIN D RECEPTOR;

ALLELE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HAPLOTYPE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; MALE; PARATHYROID ADENOMA; PARATHYROID HORMONE RELEASE; PARATHYROID TUMOR; PRIORITY JOURNAL;

ADENOMA; AGED; ALLELES; CALCITRIOL; FEMALE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RNA, MESSENGER;

EID: 0031786539     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.7.2255     Document Type: Article

References (36)

1. 3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tissue Int. 43:213-218.
2. Kremer R, Bolivar I, Goltzman D, Hendy GN. 1989 Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology. 125:935-941.
3. 3. Proc Natl Acad Sci USA. 89:8097-8101.
4. Carling T, Kindmark A, Hellman P, et al. 1995 Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med. 1:1309-1311.
5. Carling T, Kindmark A, Hellman P, Holmberg L, Åkerström G, Rastad J. 1997 Vitamin D receptor alleles b, a and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1. Biochem Biophys Res Commun. 231:329-332.
6. Mitlak B, Smith AP, Arnold A. 1996 Association of a polymorphic allele of the vitamin D receptor gene with primary hyperparathyroidism in men and women [Abstract]. J Bone Miner Res. 11:s212.
7. Nagasaka S, Ishikawa S, Matoba H, Kubota K, Murakami T, Saito T. 1996 Vitamin D receptors and hyperparathyroidism. Nat Med. 2:834.
8. Carling T, Ridefelt P, Hellman P, Rastad J, Åkerström G. 1997 Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab. 82:1772-1775.
9. Morrison NA, Cheng Qi J, Tokita A, et al. 1994 Prediction of bone density from vitamin D receptor alleles. Nature. 367:284-287.
10. Mocharala H, Butch A, Pappas A, et al. 1997 Quantification of vitamin D receptor mRNA by competitive polymerase chain reaction in PBMC: lack of correspondence with common allelic variants. J Bone Miner Res. 12:726-733.
11. Riggs BL, Nguyen TV, Melton III LJM, et al. 1995 The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res. 10:991-996.
12. Uitterlinden AG, Pols HAP, Burger H, et al. 1996 A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res. 11:1241-1248.
13. Chomczynski P, Sacchi N. 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156-159.
14. Baker AR, McDonnell DP, Hughes M, et al. 1988 Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA. 85:3294-3298.
15. Hendy GN, Kronenberg HM, Potts Jr JT, Rich A. 1981 Nucleotide sequence of cloned cDNAs encoding human preproparathyroid hormone. Proc Natl Acad Sci USA. 78:7365-7369.
16. 3. J Biol Chem. 263:2203-2208.
17. Forsberg M, Westin G. 1991 Enhancer activation by a single type of transcription factor shows cell type dependence. EMBO J. 10:2543-2551.
18. Silver J, Navey-Many T, Schmerzer H, Popovtzer M. 1986 Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest. 78:1298-1301.
19. Silver J, Naveh-Many T. 1994 Regulation of parathyroid hormone synthesis and secretion. Semin Nephrol. 14:175-194.
20. 3 and cortisol on bovine and human parathyroid cells. J Endocrinol. 123:137-142.
21. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest. 92:1436-1443.
22. Tokita A, Matsumoto H, Morrison N, et al. 1996 Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res. 11:1003-1009.
23. Beavan S, Prentice A, Yan L, Dibba B, Ralston S. 1996 Differences in the vitamin D receptor genotype and geographical variation in osteoporosis. Lancet. 348:136-137.
24. Young R, Lau E, Birjandi Z, Critchely J, Woo J. 1996 Interethnic differences in hip fracture rate and the vitamin D receptor polymorphisms. Lancet. 348:688-689.
25. Howard G, Nguyen T, Morrison N, et al. 1995 Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab. 80:2800-2805.
26. 3 in normal women [Abstract]. J Bone Miner Res. 10:s162.
27. Garnero P, Borel O, Somay-Rendu E, Arlot ME, Delmas PD. 1996 Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: The OFELY Study. J Bone Miner Res. 11:827-834.
28. 3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids. Endocrinology. 132:2639-2644.
29. 3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology. 136:1419-1425.
30. Wallfelt C, Gylfe E, Larsson R, Ljunghall S, Rastad J, Åkerström G. 1988 Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism. J Endocrinol. 116:457-464.
31. Juhlin C, Klareskog L, Nygren P, et al. 1988 Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. Endocrinology. 122:2999-3001.
32. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab. 81:1598-606.
33. Famebo F, Enberg U, Grimelius L, et al. 1997 Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab. 82:3481-3486.
34. 3 results from ligand-induced stabilization. J Biol Chem. 267:20082-20086.
35. Walters M. 1992 Newly identified actions of the vitamin D endocrine system. Endocr Rev. 13:719-764.
36. 3 in the rat parathyroid in vivo. J Clin Invest. 86:1968-1975.